Morano Susan E

SEC source: 0001225208-26-007337 · doc4.xml · nonDerivative · entry 1

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,784

SEC source: 0001225208-26-005110 · doc4.xml · nonDerivative · entry 2

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,744

F2 · kind: Grant of restricted stock in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of approximately $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant.

SEC source: 0001225208-26-005110 · doc4.xml · nonDerivative · entry 1

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,463

F1 · kind: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.

SEC source: 0001225208-26-003179 · doc4.xml · nonDerivative · entry 1

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,663

F1 · shares: Restricted stock granted in lieu of 50% of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $1,845.25, divided by the closing price of common stock on the date of grant.

SEC source: 0001225208-25-004932 · doc4.xml · nonDerivative · entry 2

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,639

F2 · kind: Grant of restricted stock in lieu of 50% yearly cash compensation. Reflects a value of approximately $62,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

SEC source: 0001225208-25-004932 · doc4.xml · nonDerivative · entry 1

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,034

F1 · kind: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.

SEC source: 0001225208-24-005970 · doc4.xml · derivative · entry 4

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,953

Underlying: Common Stock · 421 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F5 · shares: Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

F5 · derivative.exercise_date: Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

F5 · derivative.expiration_date: Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

SEC source: 0001225208-24-005970 · doc4.xml · derivative · entry 3

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,532

Underlying: Common Stock · 1,450 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4 · shares: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.

F4 · derivative.exercise_date: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.

F4 · derivative.expiration_date: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.

SEC source: 0001225208-24-005970 · doc4.xml · nonDerivative · entry 2

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,953

F2 · kind: Grant of restricted stock in lieu of 25% yearly cash compensation. Reflects a value of approximately $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

SEC source: 0001225208-24-005970 · doc4.xml · nonDerivative · entry 1

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,532

F1 · kind: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $107,500 (representing 50% of the amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.

SEC source: 0001225208-23-007373 · doc4.xml · derivative · entry 4

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,082

Underlying: Common Stock · 456 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F5 · shares: Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,428.87 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F5 · derivative.exercise_date: Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,428.87 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F5 · derivative.expiration_date: Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $24,428.87 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

SEC source: 0001225208-23-007373 · doc4.xml · derivative · entry 3

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,626

Underlying: Common Stock · 1,626 shares

Expires not disclosed

F3 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4 · shares: Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $87,094.25 (representing 50% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F4 · derivative.exercise_date: Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $87,094.25 (representing 50% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

F4 · derivative.expiration_date: Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $87,094.25 (representing 50% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

SEC source: 0001225208-23-007373 · doc4.xml · nonDerivative · entry 2

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,082

F2 · price: Grant of restricted stock in lieu of 25% yearly cash compensation, following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. Reflects a value of approximately $24,428.88 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant.

SEC source: 0001225208-23-007373 · doc4.xml · nonDerivative · entry 1

Morano Susan E · CIK 0001983791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,626

F1 · price: Grant of restricted stock to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of restricted stock vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $87,094.25 (representing 50% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of common stock on the date of grant.